Suzhou Fushilai Pharmaceutical Co., Ltd. Stock Price

SZSE:301258 Community·CN¥2.9b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

301258 Share Price Performance

CN¥32.69

4.99 (18.01%)

CN¥32.69

4.99 (18.01%)

CN¥32.69

Sun, 7 Dec 25

Share Pricen/a

301258 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks

2 Rewards

View Full Analysis

Suzhou Fushilai Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 0.85
: 16.85%
: 17.28%
: 0%

View Full Analysis

About 301258

Founded: 1997
Employees: 524
CEO: Xiangyun Qian
WebsiteView website: www.fuslai.com

Suzhou Fushilai Pharmaceutical Co., Ltd. engages in the manufacture and sale of biopharmaceutical products in China. It primarily focuses on manufacturing Alpha Lipoic Acid, L-Carnosine, and Phosphatidylcholine series of products. Its products are primarily used in medicines, dietary supplements, cosmetics, and other fields. The company also exports its products to Europe, America, Southeast Asia, and other countries. Suzhou Fushilai Pharmaceutical Co., Ltd. was founded in 1997 and is based in Changshu, China.